HMGA1 contains an AT-hook motif, which is a DNA-binding motif first described in the high-mobility group of non-histone chromosomal proteins HMGA1/2 . The AT-hook motif binds to AT-rich DNA sequences in the minor groove of B-DNA in a non-sequence specific manner . This binding property allows HMGA1 to interact with various DNA regions and influence gene expression.
HMGA1 has been implicated in several diseases, particularly in cancer. It has been demonstrated to modulate cellular proliferation, invasion, and apoptosis, often associated with a poor prognosis in various carcinomas . Additionally, HMGA1 is an important positive regulator of hepatitis B virus (HBV) transcription. It binds to a conserved ATTGG site within the enhancer II/core promoter (EII/Cp) and recruits transcription factors, enhancing viral gene expression and genome replication .
Recombinant HMGA1 refers to the artificially synthesized version of the protein, produced using recombinant DNA technology. This technology involves inserting the HMGA1 gene into a suitable expression system, such as bacteria or yeast, to produce the protein in large quantities. Recombinant HMGA1 is used in various research applications to study its structure, function, and interactions with other molecules.
Research on HMGA1 has provided valuable insights into its role in gene regulation and disease. For example, studies have shown that HMGA1-mediated upregulation of HBV transcription involves the HBV X protein (HBx) interacting with the SP1 transcription factor to activate the HMGA1 promoter . Additionally, targeting endogenous HMGA1 through RNA interference has been shown to facilitate HBV clearance in a mouse model of HBV persistence .